INHIBITING SARM1 IS MORE EFFICACIOUS THAN NICOTINAMIDE RIBOSIDE SUPPLEMENTATION FOR THE TREATMENT OF A MOUSE MODEL WITH NAFLD/NASH

Liu, YasmineScantlebery, Angelique M. L.Strotjohann, KenoRodriguez-Lopez, SandraLi, XiaoxuHomicsko, KrisztianSmith, KarenCiavarri, JeffreyBou-Sleiman, MarounHoutkooper, Riekelt H.Auwerx, Johan2024-02-202024-02-202024-02-202023-10-01https://infoscience.epfl.ch/handle/20.500.14299/204648WOS:001094865402302Life Sciences & BiomedicineINHIBITING SARM1 IS MORE EFFICACIOUS THAN NICOTINAMIDE RIBOSIDE SUPPLEMENTATION FOR THE TREATMENT OF A MOUSE MODEL WITH NAFLD/NASHtext::conference output::conference proceedings::conference paper